India plans inhalable vaccine trials.
- Published in:
- Chemistry & Industry, 2009, n. 18, p. 7
- By:
- Publication type:
- Article
Works matching DE "SERUM Institute of India Pvt. Ltd."
Results: 8
1
2
Regulatory Pathways That Facilitated Timely Registration of a New Group A Meningococcal Conjugate Vaccine for Africa’s Meningitis Belt Countries.
- Published in:
- Clinical Infectious Diseases, 2015, v. 61, p. S428, doi. 10.1093/cid/civ491
- By:
- Publication type:
- Article
3
Challenges and Opportunities While Developing a Group A Meningococcal Conjugate Vaccine Within a Product Development Partnership: A Manufacturer’s Perspective From the Serum Institute of India.
- Published in:
- Clinical Infectious Diseases, 2015, v. 61, p. S483, doi. 10.1093/cid/civ500
- By:
- Publication type:
- Article
4
The Evolution of the Meningitis Vaccine Project.
- Published in:
- Clinical Infectious Diseases, 2015, v. 61, p. S396, doi. 10.1093/cid/civ594
- By:
- Publication type:
- Article
5
News in Brief.
- Published in:
- Indian Pediatrics, 2014, v. 51, n. 5, p. 417, doi. 10.1007/s13312-014-0411-2
- By:
- Publication type:
- Article
6
India will Supply Covaxin and Covishield to Other Nations.
- Published in:
- Indian Practitioner, 2021, v. 74, n. 1, p. 49
- Publication type:
- Article
7
Safety, Health and Environment.
- Published in:
- Indian Chemical Engineer, 2011, v. 53, n. 1, p. 44, doi. 10.1080/00194506.2011.659546
- Publication type:
- Article
8
Vaccine offers meningitis hope.
- Published in:
- Nature, 2010, v. 468, n. 7321, p. 143, doi. 10.1038/468143a
- By:
- Publication type:
- Article